These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 32463333

  • 1. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3.
    Wan X, Guo D, Zhu Q, Qu R.
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep 01; 319(3):G309-G322. PubMed ID: 32463333
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 6. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H, Gao M, Shen Z, Luo B, Li R, Jiang X, Ding R, Ha Y, Wang Z, Jie W.
    Oncol Rep; 2014 Aug 12; 32(2):559-66. PubMed ID: 24889918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
    Zhou B, Sun C, Hu X, Zhan H, Zou H, Feng Y, Qiu F, Zhang S, Wu L, Zhang B.
    Cell Physiol Biochem; 2017 Aug 12; 44(5):1867-1881. PubMed ID: 29224010
    [Abstract] [Full Text] [Related]

  • 9. miR-18b attenuates cerebral ischemia/reperfusion injury through regulation of ANXA3 and PI3K/Akt signaling pathway.
    Min XL, He M, Shi Y, Xie L, Ma XJ, Cao Y.
    Brain Res Bull; 2020 Aug 12; 161():55-64. PubMed ID: 32380186
    [Abstract] [Full Text] [Related]

  • 10. MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway.
    Zhu JH, De Mello RA, Yan QL, Wang JW, Chen Y, Ye QH, Wang ZJ, Tang HJ, Huang T.
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun 01; 1866(6):165747. PubMed ID: 32109492
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis.
    Wang W, Wang J, Yang C, Wang J.
    IUBMB Life; 2021 Jun 01; 73(6):866-882. PubMed ID: 33759343
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.
    Chen Y, Jiang J, Zhao M, Luo X, Liang Z, Zhen Y, Fu Q, Deng X, Lin X, Li L, Luo R, Liu Z, Fang W.
    Oncotarget; 2016 Jul 05; 7(27):41306-41319. PubMed ID: 27191497
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR, Liu B, Zhou L, Huang YX.
    Cancer Biomark; 2019 Jul 05; 24(2):159-172. PubMed ID: 30614803
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway.
    Chen L, Sun DZ, Fu YG, Yang PZ, Lv HQ, Gao Y, Zhang XY.
    Cell Signal; 2020 Feb 05; 66():109444. PubMed ID: 31629025
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C, Yin W, Liu H.
    J Cell Biochem; 2020 Nov 05; 121(11):4505-4521. PubMed ID: 32542845
    [Abstract] [Full Text] [Related]

  • 17. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 05; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 18. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
    Xiong J, Wang D, Wei A, Lu H, Tan C, Li A, Tang J, Wang Y, He S, Liu X, Hu W.
    Exp Cell Res; 2017 Dec 15; 361(2):316-323. PubMed ID: 29111166
    [Abstract] [Full Text] [Related]

  • 19. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z.
    Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096
    [Abstract] [Full Text] [Related]

  • 20. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H.
    Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.